FG
PROF

Formula Growth’s Profound Medical PROF Stock Holding History

Formula Growth’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Sell
240,088
-1,050
-0.4% -$7.06K 0.56% 70
2026
Q1 		$1.56M Buy
241,138
+38,220
+19% +$264K 0.71% 52
2025
Q4 		$1.6M Hold
202,918
– – 0.62% 63
2025
Q3 		$992K Sell
202,918
-38,000
-16% -$194K 0.35% 93
2025
Q2 		$1.42M Sell
240,918
-5,107
-2% -$27K 0.54% 77
2025
Q1 		$1.43M Sell
246,025
-3,975
-2% -$27.4K 0.58% 67
2024
Q4 		$1.88M Buy
+250,000
New +$1.92M 0.64% 64

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $349M AUM 28.06% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $476M AUM
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Formula Growth's PROF Position: Q2 2026 in Review

Formula Growth reduced its Profound Medical (PROF) stake by 0.44% in Q2 2026, selling an estimated $7.06K and leaving 240,088 shares worth $1.6M. The position accounts for 0.56% of the portfolio, ranked #70.

Formula Growth first reported a position in PROF in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.88M in Q4 2024. 56 funds tracked by Wall St. Rank hold PROF as of Q2 2026.

  • Formula Growth held 240,088 shares of Profound Medical worth $1.6M as of Q2 2026.
  • Formula Growth sold 1,050 Profound Medical shares in Q2 2026, an estimated $7.06K.
  • Profound Medical made up 0.56% of Formula Growth's portfolio in Q2 2026, its #70 holding.
  • Formula Growth first reported a position in Profound Medical in Q4 2024 and has held it in 7 quarters since.
  • Formula Growth's Profound Medical position peaked at $1.88M in Q4 2024.
  • 56 funds tracked by Wall St. Rank held Profound Medical as of Q2 2026.

Based on Formula Growth's 13F filing for Q2 2026, filed 17 Aug 2026.